Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mina Al-Sabbagh"'
Autor:
Cliona M. Rooney, Malcolm K. Brenner, Helen E. Heslop, Carlos A. Ramos, Adrian P. Gee, Elizabeth Pacheco, April Durett, Aaron Orozco, Melissa Gates, Keli Sharpe, Conrad Russel Cruz, Gianpietro Dotti, Barbara Savoldo, Bilal Omer, Hao Liu, Rayne H. Rouce, Olga Dakhova, Darshana Raghavan, Manasa Hiregange, Tamara Tripic, Robert A. Krance, Swati Naik, Mina Al-Sabbagh, Lisa A. Rollins, Iulia Diaconu, Margaret Gilbert, Natalia Lapteva
Supplementary Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e0f71fe82cdf65f01ec3b452c7b2622
https://doi.org/10.1158/1078-0432.22472346
https://doi.org/10.1158/1078-0432.22472346
Autor:
Cliona M. Rooney, Malcolm K. Brenner, Helen E. Heslop, Carlos A. Ramos, Adrian P. Gee, Elizabeth Pacheco, April Durett, Aaron Orozco, Melissa Gates, Keli Sharpe, Conrad Russel Cruz, Gianpietro Dotti, Barbara Savoldo, Bilal Omer, Hao Liu, Rayne H. Rouce, Olga Dakhova, Darshana Raghavan, Manasa Hiregange, Tamara Tripic, Robert A. Krance, Swati Naik, Mina Al-Sabbagh, Lisa A. Rollins, Iulia Diaconu, Margaret Gilbert, Natalia Lapteva
Purpose:Current protocols for CD19 chimeric antigen receptor–expressing T cells (CD19.CAR-T cells) require recipients to tolerate preinfusion cytoreductive chemotherapy, and the presence of sufficient target antigen on normal or malignant B cells.P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04e8d2194bcd7d99c6b8cfe15c50c87f
https://doi.org/10.1158/1078-0432.c.6528198
https://doi.org/10.1158/1078-0432.c.6528198
Autor:
Bilal Omer, Tamara Tripic, Adrian P. Gee, Carlos A. Ramos, Olga Dakhova, Hao Liu, Margaret Gilbert, Manasa Hiregange, Barbara Savoldo, Helen E. Heslop, Mina Al-Sabbagh, Swati Naik, Iulia Diaconu, Elizabeth Pacheco, Malcolm K. Brenner, April G. Durett, Conrad Russel Cruz, Gianpietro Dotti, Lisa Rollins, Robert A. Krance, Darshana Raghavan, Melissa Gates, Natalia Lapteva, Keli Sharpe, Aaron Orozco, Rayne H. Rouce, Cliona M. Rooney
Publikováno v:
Clin Cancer Res
Purpose: Current protocols for CD19 chimeric antigen receptor–expressing T cells (CD19.CAR-T cells) require recipients to tolerate preinfusion cytoreductive chemotherapy, and the presence of sufficient target antigen on normal or malignant B cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::840635a584750dbf0a5f39f13904981e
https://doi.org/10.1158/1078-0432.ccr-18-3199
https://doi.org/10.1158/1078-0432.ccr-18-3199
Autor:
Cliona M. Rooney, Margaret Gilbert, Natalia Lapteva, Mina Al-Sabbagh, G. Douglas Myers, Siddhartha Ganguly, Olga Dakhova, Huimin Zhang, Sunil Abhyankar, Gary C. Doolittle, Joy M. Fulbright
Publikováno v:
Journal of Clinical Oncology. 38:e15026-e15026
e15026 Background: Despite improvements in treatment with targeted agents and immunotherapeutics metastatic melanoma still has a guarded prognosis. Many melanoma cells upregulate the disialoganglioside GD2. Early GD2 chimeric antigen receptor (CAR) T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::499516abd8c6b57306e21f540ea21018
https://doi.org/10.1200/jco.2020.38.15_suppl.e15026
https://doi.org/10.1200/jco.2020.38.15_suppl.e15026